trial · primary record
Ketamine
Healthy Volunteer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 150 |
| Primary completion | 2028-01-01 |
| Primary endpoint | To demonstrate more robust neuropharmacodynamic effects measured by neuropharmacodynamic imaging (fMRI+EEG and MEG) of ketamine 0.5 mg/kg as compared to placebo administered over 40 minutes. |
| Registry ID | NCT03065335 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:08.825Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03065335
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.